Login
Products
Login
Home
Alerts
Search
Watchlist
Products

GMM Pfaudler Ltd

GMMPFAUDLR
NSE
905.55
0.84%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

GMM Pfaudler Ltd

GMMPFAUDLR
NSE
905.55
0.84%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
4,071Cr
Close
Close Price
905.55
Industry
Industry
Glass - Others
PE
Price To Earnings
231.01
PS
Price To Sales
1.20
Revenue
Revenue
3,387Cr
Rev Gr TTM
Revenue Growth TTM
8.11%
PAT Gr TTM
PAT Growth TTM
-87.60%
Peer Comparison
How does GMMPFAUDLR stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GMMPFAUDLR
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
866912937856741785805801807795902884
Growth YoY
Revenue Growth YoY%
23.823.420.28.0-14.5-13.9-14.1-6.48.91.212.010.2
Expenses
ExpensesCr
772782795742651697712706723694781779
Operating Profit
Operating ProfitCr
941301421149089939683101122105
OPM
OPM%
10.914.315.213.312.111.311.612.010.312.713.511.9
Other Income
Other IncomeCr
1599-81110-126-5299-48
Interest Expense
Interest ExpenseCr
212022233025262527433034
Depreciation
DepreciationCr
363836363935363538363637
PBT
PBTCr
5180934731383062-343264-14
Tax
TaxCr
183026196171522-62125-5
PAT
PATCr
3350672825221540-281039-9
Growth YoY
PAT Growth YoY%
93.0-18.7-30.449.6-24.2-56.3-77.443.3-210.6-53.5158.4-122.2
NPM
NPM%
3.95.57.23.33.42.81.95.0-3.51.34.4-1.0
EPS
EPS
8.612.215.26.46.95.23.49.2-6.02.59.2-1.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
3082923534065035911,0012,5413,1783,4463,1993,387
Growth
Revenue Growth%
-5.120.914.923.917.669.4153.825.18.5-7.25.9
Expenses
ExpensesCr
2722573063444264808622,2572,7482,9712,8382,976
Operating Profit
Operating ProfitCr
3635486277111139284429476361411
OPM
OPM%
11.712.013.515.315.318.813.911.213.513.811.312.1
Other Income
Other IncomeCr
346986-1073020-17-82
Interest Expense
Interest ExpenseCr
11111310256795103133
Depreciation
DepreciationCr
108810112150133122150144148
PBT
PBTCr
283044617392681332712519648
Tax
TaxCr
9101318232155861804735
PAT
PATCr
19203143517164752101714913
Growth
PAT Growth%
6.654.737.118.540.6-10.718.6179.2-18.9-71.2-74.2
NPM
NPM%
6.16.98.810.510.112.06.33.06.65.01.50.4
EPS
EPS
4.34.67.19.711.516.216.76.537.539.011.83.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
333333339999
Reserves
ReservesCr
1481641912252663264035247929551,0141,167
Current Liabilities
Current LiabilitiesCr
80841141441451648131,0711,3911,1651,1311,419
Non Current Liabilities
Non Current LiabilitiesCr
44111721361,0839881,1601,0389431,229
Total Liabilities
Total LiabilitiesCr
2342563183894345302,4182,7283,3633,1743,1033,851
Current Assets
Current AssetsCr
1771922533083453901,3231,6892,0721,8521,8842,354
Non Current Assets
Non Current AssetsCr
58646581891401,0951,0391,2911,3221,2191,498
Total Assets
Total AssetsCr
2342563183894345302,4182,7283,3633,1743,1033,851

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
302522682727157236185284378
Investing Cash Flow
Investing Cash FlowCr
-15-18-21-24-8-50-66-117-311-32-52
Financing Cash Flow
Financing Cash FlowCr
-6-6-6-8-10-5105-55130-244-201
Net Cash Flow
Net Cash FlowCr
91-5359-281966548125
Free Cash Flow
Free Cash FlowCr
231184413-979108161221318
CFO To PAT
CFO To PAT%
159.7122.672.2158.753.537.5246.6313.787.8166.3769.0
CFO To EBITDA
CFO To EBITDA%
83.870.547.3109.135.124.0112.983.343.059.7104.7

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4183687611,0051,7543,6756,2936,6716,5905,5564,553
Price To Earnings
Price To Earnings
23.319.224.523.534.751.685.678.340.331.686.0
Price To Sales
Price To Sales
1.41.32.22.53.56.26.32.62.11.61.4
Price To Book
Price To Book
2.82.23.94.46.511.215.512.68.25.84.5
EV To EBITDA
EV To EBITDA
10.39.015.415.121.832.747.824.616.812.913.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.558.757.758.553.757.055.360.159.660.060.7
OPM
OPM%
11.712.013.515.315.318.813.911.213.513.811.3
NPM
NPM%
6.16.98.810.510.112.06.33.06.65.01.5
ROCE
ROCE%
19.118.323.227.127.726.47.513.619.018.510.7
ROE
ROE%
12.512.116.118.718.821.615.614.326.317.74.8
ROA
ROA%
8.17.99.811.011.613.42.62.86.35.41.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** GMM Pfaudler Limited is a globally integrated leader in corrosion-resistant process technologies, systems, and services for the chemical, pharmaceutical, biotech, food & beverage, energy, and emerging green technology sectors. With over six decades of heritage since its inception in 1962, the company has evolved from an India-centric manufacturer into a truly global player, operating **19 manufacturing facilities across four continents** and serving over **90% of the world’s top chemical companies**. The company is the **market leader in glass-lined equipment (GLE)**, holding 40–50% market share in key regions and commanding near-monopoly status in large-vessel segments. However, strategic diversification beyond GLE has redefined its growth trajectory, positioning it as a **one-stop provider of integrated process solutions**. --- ### **Strategic Positioning & Growth Drivers** #### 1. **Expansion into High-Growth Markets** - **Peptides & Semaglutide Manufacturing**: Actively executing a large contract with a peptide manufacturer in Southern India, leveraging proprietary **HPPS reactor technology** and advanced filtration systems developed via its Swiss subsidiary **Mavag**. - **Semiconductor & Nuclear Sectors**: The **Edlon** subsidiary in the U.S. is experiencing strong demand from the semiconductor industry. The acquisition of **HDO in Vatva, India**, has enabled entry into the nuclear sector, unlocking a new high-value growth avenue. - **Electric Vehicles (EV) & Green Technologies**: Exploring opportunities in EV battery production and is developing technology platforms for **bio-proteins, bioplastics, and mock meat**. #### 2. **Diversification Beyond Core Glass-Lined Business** - Revenue from **glass-lined equipment (GLE)** has declined to around **~50% of total revenue** (from 80–90% historically), with active efforts underway to achieve a **balanced split: 1/3 equipment, 1/3 systems, 1/3 services**. - Strategic goal: Transition from cyclical dependence on chemicals and pharma (now ~60% of business) to more stable, diversified industries including **oil & gas, petrochemicals, mining, defense, and water treatment**. - The **non-GLE (glass-lined)** portfolio now includes: - **Mixing technology** (via Mixion, Mixel, MixPro, SEMCO) - **Filtration & Drying** (Mavag) - **Sealing Tech** (Interseal) - **Alloy Equipment** (Equilloy) - **Fluoropolymers** (Edlon) - **Lab & Process Glass** (Normag) #### 3. **Global Mixing Platforms – A Growth Engine** - Completed integration of **four mixing technology platforms**: - **SEMCO (Brazil) – Metals, Minerals, Water Treatment** - **MixPro (Canada) – Oil & Gas, Pulp & Paper** - **Mixel (France/China) – Biotech, Petrochemicals** - **Mixion (India) – Chemicals, Fermentation** - **Global mixing business valued at ~$65 million**, with a **serviceable addressable market of $3 billion**. - Recently acquired **SEMCO** for **$18.5 million** to establish a South American foothold and access fast-growing mining and water treatment markets. - Mixing systems offer high margins (up to **30%+ EBITDA**) and serve critical applications like fermentation, flue gas desulfurization (FGD), and biorefining. --- ### **Operational Excellence & Global Manufacturing Strategy** #### 1. **Manufacturing Rationalization & Offshoring** - Actively shifting fabrication to **lower-cost hubs**: - **India**: Exporting ASME-certified equipment to the U.S.; transferring engineering, documentation, and production activities to improve throughput. - **Poland**: New joint venture facility operating at full capacity, serving Mavag and Switzerland; functioning as a low-cost European manufacturing hub. - Retains **local engineering, testing, and service capabilities** in higher-cost regions (U.S., Germany, Switzerland) to meet local content and quality expectations. #### 2. **Capacity Expansion & Infrastructure** - In India, the **Karamsad and Vatva (Ahmedabad)** facilities are key enablers of growth: - Commissioned India’s largest **80,000-liter glass-lined furnace** in Karamsad. - State-of-the-art **Vatva Heavy Engineering facility** equipped to handle exotic alloys, thick-walled vessels, and nuclear-grade equipment. - **Poland JV** and **U.S. local manufacturing** further strengthen regional resilience and cost competitiveness. #### 3. **Test & Innovation Centers** - Established **pilot and test centers** in **Karamsad (India), Switzerland, and North America** to enable customer trials. - Supports **flow chemistry**, continuous manufacturing, molecular distillation, acid concentration, and filtration validation. - Collaborating with **CSIR-NCL (India)** and **CPI (UK)** on decarbonization and continuous process technologies. --- ### **Technology & Innovation** #### 1. **Proprietary Technologies** - **HPPS Reactor Technology**: Proprietary, high-performance system critical for peptide manufacturing. - **MoSA Process**: In-house developed **Modular Sulfuric Acid concentration** for sustainable acid recovery from flue gas; successfully commissioned plants in Korea, China, and India. - **MAVASPHERE® Spherical Dryers**: Proven to reduce drying time from **100+ hours to under 24**, improving efficiency and ROI. - **Funda® Filter & Continuous Pressure Filter (CPF)**: Designed for viscous and challenging filtrations in specialty chemicals. #### 2. **Flow Chemistry & Continuous Processing** - Developing capabilities in **continuous manufacturing**, including pilot reactors and **lab-to-industrial scale deployment**. - Flow reactors see growing adoption in pharmaceuticals, especially for **exothermic or hazardous reactions**. - Investment in automation, digitalization, and process simulation to support future trends. --- ### **Market Performance & Financial Outlook** #### 1. **Strong Order Backlog** - **Heavy Engineering** in India holds a significant pipeline, driven by nuclear, oil & gas, and refinery expansion projects (~₹60–100 crores per ticket). - **SEMCO Brazil** has a **one-year order backlog**, with large opportunities in metals and minerals. - Systems order book shows strong traction: - **Acid recovery systems** (Korea, India, China) - **Peptide equipment in Hastelloy & stainless steel** - **Cardanol extraction skids and CNSL-to-biochemicals plants** #### 2. **Revenue Diversification & Margins** - Services now contribute **~30% of revenue**, marked by high margins and recurring business (spares, re-glassing, field service). - The **mixing business**, while currently smaller, has higher margins and faster growth potential than traditional GLE. - Management aims for **double-digit revenue growth in India**, with stable, moderate growth internationally. --- ### **Geographic Trends** | **Region** | **Key Dynamics** | |-----------|------------------| | **India** | Strong demand in agrochemicals (resuming capex), pharma (PLI-driven), oil & gas (~6% sector growth), and nuclear. Gujarat facility at **above absorption capacity**. | | **USA** | Local manufacturing base; strength in defense, semiconductors (Edlon), and services. | | **Europe** | Divergent: **Southern & Eastern Europe stronger**; **Germany sluggish** due to capex constraints. Polish facility supports European demand. | | **South America** | Rapid expansion via **SEMCO** in mining, wastewater, and renewable fuels. | | **Southeast Asia & Middle East** | Strategic focus for international expansion through agent networks and vendor approvals. | --- ### **Key Acquisitions & Integration** - **SEMCO (Brazil)** – Acquired in 2025: $65M global mixing platform now unified. - **Mixel (France/China)** & **MixPro (Canada)**: Completed in 2023; enabled global scale in mixing. - **Hydro Air Research Italia (HARI)**: Advanced **membrane separation tech** for green applications (water, bioplastics, lithium purification). - **HDO (Vatva, India)**: Enabled entry into **nuclear and heavy engineering**. - **Full acquisition of Pfaudler Group**: Made GMM Pfaudler the **ultimate holding company**, unlocking earnings, synergies, and consolidated global control. --- ### **Strategic Vision** GMM Pfaudler is transforming from a niche **glass-lined equipment supplier** into a **global leader in integrated process systems**. The strategic pillars include: 1. **Diversification** – Reduce reliance on chemicals/pharma, grow systems and services. 2. **Globalization** – Expand manufacturing, sales, and service footprint. 3. **Innovation** – Lead in flow chemistry, acid recovery, and green technologies. 4. **Operational Excellence** – Leverage India for cost-effective manufacturing and engineering support. 5. **Integration & Cross-Selling** – Unify brands under a single global portfolio to deepen customer relationships. ---